MAPT and Alzheimer disease: By the age of 40 years, virtually all people with full trisomy 21 exhibit AD pathology, marked by amyloid‐β (Aβ) plaques and neurofibrillary tangles (NFT, phosphorylated tau [p‐tau]).3, 4